nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—CHRNA2—epilepsy syndrome	0.655	1	CbGaD
Cisatracurium Besylate—CHRNA1—tongue—epilepsy syndrome	0.00354	0.261	CbGeAlD
Cisatracurium Besylate—Atracurium—CHRNA2—epilepsy syndrome	0.00177	0.244	CrCbGaD
Cisatracurium Besylate—Doxacurium chloride—CHRNA2—epilepsy syndrome	0.00151	0.207	CrCbGaD
Cisatracurium Besylate—Mivacurium—CHRNA2—epilepsy syndrome	0.00142	0.195	CrCbGaD
Cisatracurium Besylate—CHRNA2—forebrain—epilepsy syndrome	0.00124	0.0919	CbGeAlD
Cisatracurium Besylate—CHRNA1—head—epilepsy syndrome	0.000859	0.0634	CbGeAlD
Cisatracurium Besylate—CHRNB1—medulla oblongata—epilepsy syndrome	0.000837	0.0618	CbGeAlD
Cisatracurium Besylate—CHRNB1—midbrain—epilepsy syndrome	0.000765	0.0565	CbGeAlD
Cisatracurium Besylate—CHRNB1—spinal cord—epilepsy syndrome	0.000746	0.0551	CbGeAlD
Cisatracurium Besylate—CHRNA2—head—epilepsy syndrome	0.000712	0.0526	CbGeAlD
Cisatracurium Besylate—CHRNA2—nervous system—epilepsy syndrome	0.000675	0.0499	CbGeAlD
Cisatracurium Besylate—Mivacurium—CHRM3—epilepsy syndrome	0.000665	0.0914	CrCbGaD
Cisatracurium Besylate—CHRNB1—head—epilepsy syndrome	0.000663	0.049	CbGeAlD
Cisatracurium Besylate—CHRNA2—central nervous system—epilepsy syndrome	0.00065	0.048	CbGeAlD
Cisatracurium Besylate—CHRNA2—cerebellum—epilepsy syndrome	0.000636	0.047	CbGeAlD
Cisatracurium Besylate—CHRNA1—brain—epilepsy syndrome	0.000622	0.046	CbGeAlD
Cisatracurium Besylate—CHRNB1—cerebellum—epilepsy syndrome	0.000591	0.0437	CbGeAlD
Cisatracurium Besylate—Doxacurium chloride—CHRM2—epilepsy syndrome	0.000539	0.074	CrCbGaD
Cisatracurium Besylate—CHRNA2—brain—epilepsy syndrome	0.000516	0.0381	CbGeAlD
Cisatracurium Besylate—Mivacurium—CHRM2—epilepsy syndrome	0.000506	0.0696	CrCbGaD
Cisatracurium Besylate—CHRNB1—brain—epilepsy syndrome	0.00048	0.0355	CbGeAlD
Cisatracurium Besylate—Doxacurium chloride—BCHE—epilepsy syndrome	0.000449	0.0617	CrCbGaD
Cisatracurium Besylate—Mivacurium—BCHE—epilepsy syndrome	0.000422	0.058	CrCbGaD
Cisatracurium Besylate—Immune system disorder—Carbamazepine—epilepsy syndrome	0.000304	0.00177	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Carbamazepine—epilepsy syndrome	0.000304	0.00176	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000302	0.00175	CcSEcCtD
Cisatracurium Besylate—Flushing—Lamotrigine—epilepsy syndrome	0.000302	0.00175	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000302	0.00175	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Propofol—epilepsy syndrome	0.000301	0.00175	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Pregabalin—epilepsy syndrome	0.000298	0.00173	CcSEcCtD
Cisatracurium Besylate—Convulsion—Vigabatrin—epilepsy syndrome	0.000298	0.00173	CcSEcCtD
Cisatracurium Besylate—Rash—Trimethadione—epilepsy syndrome	0.000297	0.00172	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Trimethadione—epilepsy syndrome	0.000297	0.00172	CcSEcCtD
Cisatracurium Besylate—Urticaria—Clobazam—epilepsy syndrome	0.000296	0.00172	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Midazolam—epilepsy syndrome	0.000296	0.00172	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Lamotrigine—epilepsy syndrome	0.000295	0.00171	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Midazolam—epilepsy syndrome	0.000295	0.00171	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Gabapentin—epilepsy syndrome	0.000295	0.00171	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Midazolam—epilepsy syndrome	0.000294	0.0017	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Lamotrigine—epilepsy syndrome	0.000293	0.0017	CcSEcCtD
Cisatracurium Besylate—Erythema—Carbamazepine—epilepsy syndrome	0.000293	0.0017	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000293	0.0017	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.000291	0.00169	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Levetiracetam—epilepsy syndrome	0.00029	0.00168	CcSEcCtD
Cisatracurium Besylate—Pruritus—Rufinamide—epilepsy syndrome	0.00029	0.00168	CcSEcCtD
Cisatracurium Besylate—Hypotension—Propofol—epilepsy syndrome	0.000289	0.00167	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000288	0.00167	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.000286	0.00166	CcSEcCtD
Cisatracurium Besylate—Erythema—Lamotrigine—epilepsy syndrome	0.000283	0.00164	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000283	0.00164	CcSEcCtD
Cisatracurium Besylate—Hypertension—Felbamate—epilepsy syndrome	0.000283	0.00164	CcSEcCtD
Cisatracurium Besylate—Angioedema—Clonazepam—epilepsy syndrome	0.000283	0.00164	CcSEcCtD
Cisatracurium Besylate—Hypotension—Midazolam—epilepsy syndrome	0.000282	0.00164	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000281	0.00163	CcSEcCtD
Cisatracurium Besylate—Angioedema—Oxcarbazepine—epilepsy syndrome	0.000279	0.00162	CcSEcCtD
Cisatracurium Besylate—Convulsion—Zonisamide—epilepsy syndrome	0.000278	0.00161	CcSEcCtD
Cisatracurium Besylate—Hypertension—Zonisamide—epilepsy syndrome	0.000277	0.00161	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000276	0.0016	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Propofol—epilepsy syndrome	0.000275	0.0016	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000275	0.0016	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Gabapentin—epilepsy syndrome	0.000273	0.00159	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Vigabatrin—epilepsy syndrome	0.000273	0.00158	CcSEcCtD
Cisatracurium Besylate—Pruritus—Lacosamide—epilepsy syndrome	0.000272	0.00158	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000271	0.00157	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Diazepam—epilepsy syndrome	0.000271	0.00157	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Diazepam—epilepsy syndrome	0.00027	0.00157	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Midazolam—epilepsy syndrome	0.000269	0.00156	CcSEcCtD
Cisatracurium Besylate—Hypotension—Fosphenytoin—epilepsy syndrome	0.000269	0.00156	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Diazepam—epilepsy syndrome	0.000268	0.00156	CcSEcCtD
Cisatracurium Besylate—Angioedema—Carbamazepine—epilepsy syndrome	0.000268	0.00155	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000268	0.00155	CcSEcCtD
Cisatracurium Besylate—Convulsion—Phenytoin—epilepsy syndrome	0.000266	0.00154	CcSEcCtD
Cisatracurium Besylate—Hypertension—Phenytoin—epilepsy syndrome	0.000265	0.00154	CcSEcCtD
Cisatracurium Besylate—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000265	0.00154	CcSEcCtD
Cisatracurium Besylate—Urticaria—Acetazolamide—epilepsy syndrome	0.000264	0.00153	CcSEcCtD
Cisatracurium Besylate—Pruritus—Clobazam—epilepsy syndrome	0.000264	0.00153	CcSEcCtD
Cisatracurium Besylate—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000264	0.00153	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Gabapentin—epilepsy syndrome	0.000264	0.00153	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Valproic Acid—epilepsy syndrome	0.000263	0.00153	CcSEcCtD
Cisatracurium Besylate—Rash—Phenobarbital—epilepsy syndrome	0.000263	0.00153	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Phenobarbital—epilepsy syndrome	0.000263	0.00152	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.000261	0.00152	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Felbamate—epilepsy syndrome	0.000261	0.00151	CcSEcCtD
Cisatracurium Besylate—Angioedema—Lamotrigine—epilepsy syndrome	0.000259	0.0015	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000258	0.0015	CcSEcCtD
Cisatracurium Besylate—Hypotension—Diazepam—epilepsy syndrome	0.000258	0.0015	CcSEcCtD
Cisatracurium Besylate—Rash—Rufinamide—epilepsy syndrome	0.000258	0.0015	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Rufinamide—epilepsy syndrome	0.000258	0.0015	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000257	0.00149	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000257	0.00149	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000256	0.00169	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—epilepsy syndrome	0.000256	0.00169	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—epilepsy syndrome	0.000256	0.00169	CbGpPWpGaD
Cisatracurium Besylate—Tachycardia—Zonisamide—epilepsy syndrome	0.000256	0.00148	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Zonisamide—epilepsy syndrome	0.000254	0.00148	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Valproic Acid—epilepsy syndrome	0.000254	0.00147	CcSEcCtD
Cisatracurium Besylate—Convulsion—Carbamazepine—epilepsy syndrome	0.000254	0.00147	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNQ3—epilepsy syndrome	0.000254	0.00168	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNQ2—epilepsy syndrome	0.000254	0.00168	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—CHRNA2—epilepsy syndrome	0.000254	0.00168	CbGpPWpGaD
Cisatracurium Besylate—Hypertension—Carbamazepine—epilepsy syndrome	0.000253	0.00147	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000252	0.00146	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.000251	0.00166	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.000251	0.00166	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000251	0.00166	CbGpPWpGaD
Cisatracurium Besylate—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000251	0.00145	CcSEcCtD
Cisatracurium Besylate—Hypotension—Felbamate—epilepsy syndrome	0.00025	0.00145	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000249	0.00145	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000248	0.00144	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000248	0.00144	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000246	0.00163	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Diazepam—epilepsy syndrome	0.000246	0.00143	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Clonazepam—epilepsy syndrome	0.000246	0.00143	CcSEcCtD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABBR1—epilepsy syndrome	0.000246	0.00163	CbGpPWpGaD
Cisatracurium Besylate—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000246	0.00143	CcSEcCtD
Cisatracurium Besylate—Convulsion—Lamotrigine—epilepsy syndrome	0.000246	0.00142	CcSEcCtD
Cisatracurium Besylate—Urticaria—Propofol—epilepsy syndrome	0.000245	0.00142	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Clonazepam—epilepsy syndrome	0.000245	0.00142	CcSEcCtD
Cisatracurium Besylate—Hypotension—Zonisamide—epilepsy syndrome	0.000245	0.00142	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Phenytoin—epilepsy syndrome	0.000245	0.00142	CcSEcCtD
Cisatracurium Besylate—Hypertension—Lamotrigine—epilepsy syndrome	0.000245	0.00142	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000245	0.00142	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.000244	0.00161	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB2—epilepsy syndrome	0.000244	0.00161	CbGpPWpGaD
Cisatracurium Besylate—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000243	0.00141	CcSEcCtD
Cisatracurium Besylate—Rash—Lacosamide—epilepsy syndrome	0.000242	0.00141	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000242	0.00141	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Lacosamide—epilepsy syndrome	0.000242	0.00141	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNQ3—epilepsy syndrome	0.000241	0.00159	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNQ2—epilepsy syndrome	0.000241	0.00159	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNB1—epilepsy syndrome	0.000241	0.00159	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—CACNB4—epilepsy syndrome	0.000241	0.00159	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—CACNA2D2—epilepsy syndrome	0.000241	0.00159	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Midazolam—epilepsy syndrome	0.00024	0.00139	CcSEcCtD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—epilepsy syndrome	0.00024	0.00159	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—epilepsy syndrome	0.00024	0.00159	CbGpPWpGaD
Cisatracurium Besylate—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000239	0.00139	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.000239	0.00158	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.000239	0.00158	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Felbamate—epilepsy syndrome	0.000239	0.00138	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Pregabalin—epilepsy syndrome	0.000238	0.00138	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.000238	0.00157	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000238	0.00157	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000238	0.00157	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000238	0.00157	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Clonazepam—epilepsy syndrome	0.000236	0.00137	CcSEcCtD
Cisatracurium Besylate—Rash—Clobazam—epilepsy syndrome	0.000235	0.00136	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Clobazam—epilepsy syndrome	0.000235	0.00136	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Valproic Acid—epilepsy syndrome	0.000235	0.00136	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000235	0.00136	CcSEcCtD
Cisatracurium Besylate—Hypotension—Phenytoin—epilepsy syndrome	0.000234	0.00136	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000234	0.00136	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Carbamazepine—epilepsy syndrome	0.000234	0.00135	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Zonisamide—epilepsy syndrome	0.000233	0.00135	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000233	0.00135	CcSEcCtD
Cisatracurium Besylate—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000233	0.00135	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Carbamazepine—epilepsy syndrome	0.000232	0.00135	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.000232	0.00153	CbGpPWpGaD
Cisatracurium Besylate—Muscular weakness—Topiramate—epilepsy syndrome	0.00023	0.00133	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.00023	0.00133	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GABRG2—epilepsy syndrome	0.00023	0.00152	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNH1—epilepsy syndrome	0.00023	0.00152	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—epilepsy syndrome	0.000229	0.00151	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Fosphenytoin—epilepsy syndrome	0.000229	0.00133	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—CACNB4—epilepsy syndrome	0.000229	0.00151	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNB1—epilepsy syndrome	0.000229	0.00151	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—CACNA2D2—epilepsy syndrome	0.000229	0.00151	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000227	0.0015	CbGpPWpGaD
Cisatracurium Besylate—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000227	0.00132	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—NSF—epilepsy syndrome	0.000226	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—SYN1—epilepsy syndrome	0.000226	0.0015	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.000226	0.00149	CbGpPWpGaD
Cisatracurium Besylate—Tachycardia—Lamotrigine—epilepsy syndrome	0.000226	0.00131	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Clonazepam—epilepsy syndrome	0.000225	0.00131	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000224	0.00148	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Carbamazepine—epilepsy syndrome	0.000224	0.0013	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Phenytoin—epilepsy syndrome	0.000223	0.0013	CcSEcCtD
Cisatracurium Besylate—Urticaria—Vigabatrin—epilepsy syndrome	0.000223	0.00129	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Midazolam—epilepsy syndrome	0.000223	0.00129	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000222	0.00129	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—STXBP1—epilepsy syndrome	0.00022	0.00145	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00022	0.00128	CcSEcCtD
Cisatracurium Besylate—Urticaria—Diazepam—epilepsy syndrome	0.00022	0.00127	CcSEcCtD
Cisatracurium Besylate—Pruritus—Propofol—epilepsy syndrome	0.000219	0.00127	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Gabapentin—epilepsy syndrome	0.000218	0.00127	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNH1—epilepsy syndrome	0.000218	0.00144	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GABRG2—epilepsy syndrome	0.000218	0.00144	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000218	0.00144	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000218	0.00144	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000218	0.00144	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000218	0.00144	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—epilepsy syndrome	0.000217	0.00144	CbGpPWpGaD
Cisatracurium Besylate—Flushing—Pregabalin—epilepsy syndrome	0.000217	0.00126	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.000216	0.00143	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.000216	0.00143	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.000216	0.00143	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.000216	0.00143	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.000216	0.00143	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—SLC1A1—epilepsy syndrome	0.000214	0.00142	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Midazolam—epilepsy syndrome	0.000214	0.00124	CcSEcCtD
Cisatracurium Besylate—CHRNA1—ErbB2/ErbB3 signaling events—FOS—epilepsy syndrome	0.000214	0.00141	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000214	0.00141	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000213	0.00124	CcSEcCtD
Cisatracurium Besylate—Urticaria—Felbamate—epilepsy syndrome	0.000213	0.00123	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Pregabalin—epilepsy syndrome	0.000212	0.00123	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Pregabalin—epilepsy syndrome	0.000211	0.00123	CcSEcCtD
Cisatracurium Besylate—Pruritus—Levetiracetam—epilepsy syndrome	0.000211	0.00123	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000211	0.00122	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000211	0.00122	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.00021	0.00138	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABBR1—epilepsy syndrome	0.000209	0.00138	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Zonisamide—epilepsy syndrome	0.000208	0.00121	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000207	0.0012	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000207	0.00137	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000207	0.00137	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000207	0.00137	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000207	0.00137	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—epilepsy syndrome	0.000206	0.00136	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000206	0.0012	CcSEcCtD
Cisatracurium Besylate—Angioedema—Valproic Acid—epilepsy syndrome	0.000206	0.00119	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—KCNJ10—epilepsy syndrome	0.000205	0.00135	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GRIA4—epilepsy syndrome	0.000205	0.00135	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—CACNA1A—epilepsy syndrome	0.000205	0.00135	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GABRA5—epilepsy syndrome	0.000205	0.00135	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—ABAT—epilepsy syndrome	0.000205	0.00135	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—epilepsy syndrome	0.000204	0.00135	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—epilepsy syndrome	0.000204	0.00135	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000204	0.00118	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Diazepam—epilepsy syndrome	0.000204	0.00118	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000203	0.00134	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000202	0.00134	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000202	0.00134	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000202	0.00134	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000202	0.00134	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000202	0.00134	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Clonazepam—epilepsy syndrome	0.0002	0.00116	CcSEcCtD
Cisatracurium Besylate—Urticaria—Phenytoin—epilepsy syndrome	0.000199	0.00116	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000199	0.00132	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABBR1—epilepsy syndrome	0.000199	0.00131	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Vigabatrin—epilepsy syndrome	0.000199	0.00115	CcSEcCtD
Cisatracurium Besylate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000198	0.00115	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—ARHGEF9—epilepsy syndrome	0.000196	0.0013	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GABRB3—epilepsy syndrome	0.000196	0.0013	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—SLC17A7—epilepsy syndrome	0.000196	0.0013	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GABRA1—epilepsy syndrome	0.000196	0.0013	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Diazepam—epilepsy syndrome	0.000196	0.00113	CcSEcCtD
Cisatracurium Besylate—Rash—Propofol—epilepsy syndrome	0.000195	0.00113	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Propofol—epilepsy syndrome	0.000195	0.00113	CcSEcCtD
Cisatracurium Besylate—Hypertension—Valproic Acid—epilepsy syndrome	0.000194	0.00113	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000194	0.00128	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—epilepsy syndrome	0.000194	0.00128	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—epilepsy syndrome	0.000194	0.00128	CbGpPWpGaD
Cisatracurium Besylate—Immune system disorder—Gabapentin—epilepsy syndrome	0.000194	0.00112	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000193	0.00112	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—epilepsy syndrome	0.000193	0.00128	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000193	0.00128	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000193	0.00112	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—NSF—epilepsy syndrome	0.000192	0.00127	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—SYN1—epilepsy syndrome	0.000192	0.00127	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GLUL—epilepsy syndrome	0.000192	0.00127	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000192	0.00127	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000192	0.00127	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000192	0.00127	CbGpPWpGaD
Cisatracurium Besylate—Rash—Midazolam—epilepsy syndrome	0.000191	0.00111	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.00019	0.0011	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Midazolam—epilepsy syndrome	0.00019	0.0011	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.00019	0.00126	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Carbamazepine—epilepsy syndrome	0.00019	0.0011	CcSEcCtD
Cisatracurium Besylate—Pruritus—Felbamate—epilepsy syndrome	0.000189	0.0011	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—GRIA2—epilepsy syndrome	0.000189	0.00125	CbGpPWpGaD
Cisatracurium Besylate—Rash—Levetiracetam—epilepsy syndrome	0.000188	0.00109	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000188	0.00109	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—STXBP1—epilepsy syndrome	0.000187	0.00124	CbGpPWpGaD
Cisatracurium Besylate—Erythema—Gabapentin—epilepsy syndrome	0.000187	0.00108	CcSEcCtD
Cisatracurium Besylate—Angioedema—Pregabalin—epilepsy syndrome	0.000186	0.00108	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000186	0.00108	CcSEcCtD
Cisatracurium Besylate—Pruritus—Zonisamide—epilepsy syndrome	0.000185	0.00107	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000185	0.00122	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000185	0.00107	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000184	0.00107	CcSEcCtD
Cisatracurium Besylate—Urticaria—Lamotrigine—epilepsy syndrome	0.000184	0.00107	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000184	0.00107	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Topiramate—epilepsy syndrome	0.000184	0.00107	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—epilepsy syndrome	0.000184	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000183	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—SYN1—epilepsy syndrome	0.000183	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—NSF—epilepsy syndrome	0.000183	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—SLC1A1—epilepsy syndrome	0.000182	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—SLC1A2—epilepsy syndrome	0.000182	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GRIK1—epilepsy syndrome	0.000182	0.00121	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—CHRNA7—epilepsy syndrome	0.000182	0.00121	CbGpPWpGaD
Cisatracurium Besylate—Rash—Fosphenytoin—epilepsy syndrome	0.000182	0.00105	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000181	0.00105	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000181	0.00119	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.00018	0.00119	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.00018	0.00119	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.00018	0.00119	CbGpPWpGaD
Cisatracurium Besylate—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.00018	0.00105	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Valproic Acid—epilepsy syndrome	0.000179	0.00104	CcSEcCtD
Cisatracurium Besylate—Pruritus—Clonazepam—epilepsy syndrome	0.000179	0.00104	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Valproic Acid—epilepsy syndrome	0.000179	0.00104	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—STXBP1—epilepsy syndrome	0.000178	0.00117	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—epilepsy syndrome	0.000178	0.00117	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Phenytoin—epilepsy syndrome	0.000177	0.00103	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000177	0.00103	CcSEcCtD
Cisatracurium Besylate—Rash—Vigabatrin—epilepsy syndrome	0.000177	0.00103	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000177	0.00103	CcSEcCtD
Cisatracurium Besylate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000176	0.00102	CcSEcCtD
Cisatracurium Besylate—Convulsion—Pregabalin—epilepsy syndrome	0.000176	0.00102	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000176	0.00102	CcSEcCtD
Cisatracurium Besylate—Hypertension—Pregabalin—epilepsy syndrome	0.000176	0.00102	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—epilepsy syndrome	0.000175	0.00116	CbGpPWpGaD
Cisatracurium Besylate—Rash—Diazepam—epilepsy syndrome	0.000174	0.00101	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Diazepam—epilepsy syndrome	0.000174	0.00101	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GABRA5—epilepsy syndrome	0.000174	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—CACNA1A—epilepsy syndrome	0.000174	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIA4—epilepsy syndrome	0.000174	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNJ10—epilepsy syndrome	0.000174	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—ABAT—epilepsy syndrome	0.000174	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GABRB2—epilepsy syndrome	0.000174	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—epilepsy syndrome	0.000173	0.00115	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—SLC1A1—epilepsy syndrome	0.000173	0.00114	CbGpPWpGaD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000172	0.000999	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000172	0.00114	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000172	0.00114	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—ErbB2/ErbB3 signaling events—MTOR—epilepsy syndrome	0.000172	0.00114	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Valproic Acid—epilepsy syndrome	0.000172	0.000996	CcSEcCtD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—epilepsy syndrome	0.000172	0.00113	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GAD2—epilepsy syndrome	0.000171	0.00113	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000171	0.00113	CbGpPWpGaD
Cisatracurium Besylate—Angioedema—Gabapentin—epilepsy syndrome	0.000171	0.00099	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00017	0.000989	CcSEcCtD
Cisatracurium Besylate—Pruritus—Carbamazepine—epilepsy syndrome	0.000169	0.000982	CcSEcCtD
Cisatracurium Besylate—Rash—Felbamate—epilepsy syndrome	0.000169	0.000979	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Felbamate—epilepsy syndrome	0.000169	0.000978	CcSEcCtD
Cisatracurium Besylate—Flushing—Topiramate—epilepsy syndrome	0.000167	0.000971	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GABRB3—epilepsy syndrome	0.000167	0.0011	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—ARHGEF9—epilepsy syndrome	0.000167	0.0011	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—SLC17A7—epilepsy syndrome	0.000167	0.0011	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GABRA1—epilepsy syndrome	0.000167	0.0011	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—epilepsy syndrome	0.000167	0.0011	CbGpPWpGaD
Cisatracurium Besylate—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000166	0.000964	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNJ10—epilepsy syndrome	0.000165	0.00109	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—ABAT—epilepsy syndrome	0.000165	0.00109	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIA4—epilepsy syndrome	0.000165	0.00109	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GABRA5—epilepsy syndrome	0.000165	0.00109	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—CACNA1A—epilepsy syndrome	0.000165	0.00109	CbGpPWpGaD
Cisatracurium Besylate—Rash—Zonisamide—epilepsy syndrome	0.000165	0.000958	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000165	0.00109	CbGpPWpGaD
Cisatracurium Besylate—Dermatitis—Zonisamide—epilepsy syndrome	0.000165	0.000957	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000164	0.000951	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Topiramate—epilepsy syndrome	0.000164	0.00095	CcSEcCtD
Cisatracurium Besylate—Pruritus—Lamotrigine—epilepsy syndrome	0.000164	0.000949	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GLUL—epilepsy syndrome	0.000164	0.00108	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000163	0.00108	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000163	0.00108	CbGpPWpGaD
Cisatracurium Besylate—Immune system disorder—Topiramate—epilepsy syndrome	0.000163	0.000945	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000163	0.000945	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000163	0.000943	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—KCNMA1—epilepsy syndrome	0.000163	0.00107	CbGpPWpGaD
Cisatracurium Besylate—Tachycardia—Pregabalin—epilepsy syndrome	0.000162	0.000941	CcSEcCtD
Cisatracurium Besylate—Convulsion—Gabapentin—epilepsy syndrome	0.000162	0.000938	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Pregabalin—epilepsy syndrome	0.000161	0.000936	CcSEcCtD
Cisatracurium Besylate—Hypertension—Gabapentin—epilepsy syndrome	0.000161	0.000935	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIA2—epilepsy syndrome	0.000161	0.00106	CbGpPWpGaD
Cisatracurium Besylate—Rash—Clonazepam—epilepsy syndrome	0.000159	0.000923	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Clonazepam—epilepsy syndrome	0.000159	0.000922	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—ARHGEF9—epilepsy syndrome	0.000158	0.00105	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GABRB3—epilepsy syndrome	0.000158	0.00105	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—SLC17A7—epilepsy syndrome	0.000158	0.00105	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GABRA1—epilepsy syndrome	0.000158	0.00105	CbGpPWpGaD
Cisatracurium Besylate—Rash—Phenytoin—epilepsy syndrome	0.000158	0.000917	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Phenytoin—epilepsy syndrome	0.000158	0.000916	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000158	0.000916	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000157	0.00104	CbGpPWpGaD
Cisatracurium Besylate—Rash—Oxcarbazepine—epilepsy syndrome	0.000157	0.000912	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000157	0.000911	CcSEcCtD
Cisatracurium Besylate—Erythema—Topiramate—epilepsy syndrome	0.000157	0.000911	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000157	0.00104	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GLUL—epilepsy syndrome	0.000155	0.00103	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Pregabalin—epilepsy syndrome	0.000155	0.000901	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000155	0.00103	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—SLC1A2—epilepsy syndrome	0.000155	0.00102	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—KCNJ11—epilepsy syndrome	0.000155	0.00102	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—SLC1A3—epilepsy syndrome	0.000155	0.00102	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—CHRNA7—epilepsy syndrome	0.000155	0.00102	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GRIK2—epilepsy syndrome	0.000155	0.00102	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIK1—epilepsy syndrome	0.000155	0.00102	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—ErbB2/ErbB3 signaling events—JUN—epilepsy syndrome	0.000154	0.00101	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000153	0.00101	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000153	0.00101	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000153	0.00101	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIA2—epilepsy syndrome	0.000153	0.00101	CbGpPWpGaD
Cisatracurium Besylate—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000152	0.000884	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—epilepsy syndrome	0.000151	0.000997	CbGpPWpGaD
Cisatracurium Besylate—Rash—Carbamazepine—epilepsy syndrome	0.000151	0.000875	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000151	0.000875	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.00015	0.000988	CbGpPWpGaD
Cisatracurium Besylate—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000149	0.000867	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Gabapentin—epilepsy syndrome	0.000149	0.000863	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—GAD1—epilepsy syndrome	0.000149	0.000982	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Pregabalin—epilepsy syndrome	0.000148	0.000859	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Gabapentin—epilepsy syndrome	0.000148	0.000859	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GABRB2—epilepsy syndrome	0.000148	0.000978	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—epilepsy syndrome	0.000148	0.000975	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—SLC1A2—epilepsy syndrome	0.000147	0.000973	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—CHRNA7—epilepsy syndrome	0.000147	0.000973	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIK1—epilepsy syndrome	0.000147	0.000973	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Valproic Acid—epilepsy syndrome	0.000146	0.000847	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—epilepsy syndrome	0.000146	0.000964	CbGpPWpGaD
Cisatracurium Besylate—Rash—Lamotrigine—epilepsy syndrome	0.000146	0.000846	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GAD2—epilepsy syndrome	0.000146	0.000963	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000146	0.000963	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000146	0.000963	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000146	0.000963	CbGpPWpGaD
Cisatracurium Besylate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000146	0.000845	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000145	0.00096	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—epilepsy syndrome	0.000143	0.000947	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Gabapentin—epilepsy syndrome	0.000142	0.000826	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—GABBR1—epilepsy syndrome	0.000142	0.000937	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GABRB2—epilepsy syndrome	0.000141	0.000929	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—epilepsy syndrome	0.00014	0.000926	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—epilepsy syndrome	0.000139	0.000916	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GAD2—epilepsy syndrome	0.000139	0.000915	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNMA1—epilepsy syndrome	0.000138	0.000913	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GRIN2A—epilepsy syndrome	0.000138	0.000913	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GRIA1—epilepsy syndrome	0.000138	0.000913	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—SLC6A1—epilepsy syndrome	0.000138	0.000913	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000138	0.000912	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—ErbB2/ErbB3 signaling events—SRC—epilepsy syndrome	0.000138	0.00091	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000137	0.000903	CbGpPWpGaD
Cisatracurium Besylate—Convulsion—Topiramate—epilepsy syndrome	0.000136	0.000789	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Gabapentin—epilepsy syndrome	0.000136	0.000788	CcSEcCtD
Cisatracurium Besylate—Hypertension—Topiramate—epilepsy syndrome	0.000136	0.000787	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000135	0.000786	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000133	0.000882	CbGpPWpGaD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000133	0.00077	CcSEcCtD
Cisatracurium Besylate—Urticaria—Pregabalin—epilepsy syndrome	0.000132	0.000766	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000132	0.000872	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—KCNJ11—epilepsy syndrome	0.000132	0.000871	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIK2—epilepsy syndrome	0.000132	0.000871	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—SLC1A3—epilepsy syndrome	0.000132	0.000871	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNMA1—epilepsy syndrome	0.000131	0.000868	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—CHRNB2—epilepsy syndrome	0.000131	0.000865	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.00013	0.000862	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Valproic Acid—epilepsy syndrome	0.00013	0.000754	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000129	0.000852	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GAD1—epilepsy syndrome	0.000126	0.000835	CbGpPWpGaD
Cisatracurium Besylate—Nervous system disorder—Topiramate—epilepsy syndrome	0.000126	0.000729	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000125	0.000828	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—KCNJ11—epilepsy syndrome	0.000125	0.000828	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—SLC1A3—epilepsy syndrome	0.000125	0.000828	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIK2—epilepsy syndrome	0.000125	0.000828	CbGpPWpGaD
Cisatracurium Besylate—Tachycardia—Topiramate—epilepsy syndrome	0.000125	0.000726	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Topiramate—epilepsy syndrome	0.000124	0.000722	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000122	0.00071	CcSEcCtD
Cisatracurium Besylate—Urticaria—Gabapentin—epilepsy syndrome	0.000121	0.000702	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GABBR1—epilepsy syndrome	0.000121	0.000797	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GAD1—epilepsy syndrome	0.00012	0.000794	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Topiramate—epilepsy syndrome	0.00012	0.000695	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—CHRNA4—epilepsy syndrome	0.000119	0.000785	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Pregabalin—epilepsy syndrome	0.000118	0.000682	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIA1—epilepsy syndrome	0.000118	0.000777	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIN2A—epilepsy syndrome	0.000118	0.000777	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—SLC6A1—epilepsy syndrome	0.000118	0.000777	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000116	0.000768	CbGpPWpGaD
Cisatracurium Besylate—Rash—Valproic Acid—epilepsy syndrome	0.000116	0.000672	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000116	0.000672	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—GABBR1—epilepsy syndrome	0.000115	0.000757	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Topiramate—epilepsy syndrome	0.000114	0.000663	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000113	0.00075	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000112	0.000651	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIA1—epilepsy syndrome	0.000112	0.000738	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—SLC6A1—epilepsy syndrome	0.000112	0.000738	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIN2A—epilepsy syndrome	0.000112	0.000738	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—CHRNB2—epilepsy syndrome	0.000111	0.000735	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.000111	0.000733	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.00011	0.00073	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.00011	0.000725	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000108	0.000712	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Gabapentin—epilepsy syndrome	0.000108	0.000625	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—CHRNB2—epilepsy syndrome	0.000106	0.000699	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.000105	0.000696	CbGpPWpGaD
Cisatracurium Besylate—Rash—Pregabalin—epilepsy syndrome	0.000105	0.000608	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—BCHE—epilepsy syndrome	0.000105	0.000692	CbGpPWpGaD
Cisatracurium Besylate—Dermatitis—Pregabalin—epilepsy syndrome	0.000105	0.000607	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000104	0.000689	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	0.000103	0.000682	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—DLG4—epilepsy syndrome	0.000102	0.000676	CbGpPWpGaD
Cisatracurium Besylate—Urticaria—Topiramate—epilepsy syndrome	0.000102	0.000591	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—CHRNA4—epilepsy syndrome	0.000101	0.000668	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—GRIN2B—epilepsy syndrome	9.99e-05	0.00066	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—PLCB1—epilepsy syndrome	9.88e-05	0.000653	CbGpPWpGaD
Cisatracurium Besylate—Rash—Gabapentin—epilepsy syndrome	9.61e-05	0.000557	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—CHRNA4—epilepsy syndrome	9.6e-05	0.000634	CbGpPWpGaD
Cisatracurium Besylate—Dermatitis—Gabapentin—epilepsy syndrome	9.6e-05	0.000557	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Topiramate—epilepsy syndrome	9.44e-05	0.000548	CcSEcCtD
Cisatracurium Besylate—Pruritus—Topiramate—epilepsy syndrome	9.07e-05	0.000526	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—BCHE—epilepsy syndrome	8.91e-05	0.000589	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	8.77e-05	0.00058	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—DLG4—epilepsy syndrome	8.69e-05	0.000574	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—epilepsy syndrome	8.56e-05	0.000565	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—GRIN2B—epilepsy syndrome	8.5e-05	0.000561	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—BCHE—epilepsy syndrome	8.46e-05	0.000559	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—PLCB1—epilepsy syndrome	8.4e-05	0.000555	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	8.33e-05	0.000551	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—DLG4—epilepsy syndrome	8.26e-05	0.000546	CbGpPWpGaD
Cisatracurium Besylate—Rash—Topiramate—epilepsy syndrome	8.08e-05	0.000469	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Topiramate—epilepsy syndrome	8.07e-05	0.000468	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—GRIN2B—epilepsy syndrome	8.07e-05	0.000533	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—PLCB1—epilepsy syndrome	7.98e-05	0.000528	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	7.76e-05	0.000512	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	6.59e-05	0.000436	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	6.27e-05	0.000414	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Neuronal System—PRKCB—epilepsy syndrome	5.94e-05	0.000393	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Neuronal System—PRKCB—epilepsy syndrome	5.05e-05	0.000334	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neuronal System—PRKCB—epilepsy syndrome	4.8e-05	0.000317	CbGpPWpGaD
